Sponsored Links


Displaying cisplatin PowerPoint Presentations

NSCLC Approved 1st + 2nd Line Rx - Food and Drug Administration PPT

Presentation Summary : NSCLC Approved 1st & 2nd Line Rx Vinorelbine vs 5-FU/LV Navelbine/cisplatin Gemcitabine/cisplatin Paclitaxel/cisplatin Docetaxel/cisplatin Docetaxel - 2nd line ...

Source : http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm123836.ppt

Alimta - Smith College PPT

Presentation Summary : Alimta (Pemetrexed) Presented By: Rachael Germansky Overview Alimta Overview Cancer Lung Cancer Mesothelioma Alimta Alimta and Cisplatin Future Applications Alimta ...

Source : http://www.science.smith.edu/departments/Biochem/Chm_357/presentations/Alimta.ppt

Drug - Device Combination Issues : DODP Perspective PPT

Presentation Summary : ... Cisplatin Labels which include indications for use in combination with cisplatin for NSCLC gemcitabine paclitaxel vinorelbine docetaxel Cisplatin label does ...

Source : http://www.fda.gov/downloads/CombinationProducts/MeetingsConferencesWorkshops/ucm118194.ppt

Chemotherapy Drugs - Washington Association-Nurse PPT

Presentation Summary : ... Atenolol Cisplatin 5-flurouracil Bleomycin Pre-op VSS: BP 130/88, HR 72, RR 16, SpO2 96% Lungs CTA Heart tones normal Airway: MP1 , TM3, MO3 Labs: ...

Source : http://www.wana-crna.org/Chemo%20drugs%20case%20presentation.ppt

Ovarian Cancer PPT

Presentation Summary : Historical GOG trials Points Cisplatin/Paclitaxel became standard of care for ovarian cancer in 1996 (GOG #111) Platinum agents are the single most effective agents ...

Source : http://www.mc.uky.edu/obg/Divisions/GynOnc/ONC/2011%20Epithelial%20Ovarian%20Cancer_Dr%20DeSimone.ppt

Hemolytic-Uremic Syndrome - Welcome — UNC School of Medicine PPT

Presentation Summary : ... 37% Drug-Associated: 13% Cyclosporine Tacrolimus Mitomycin C Bleomycin and cisplatin Gemcitabine Quinine Ticlopidine and clopidogrel Autoimmune Disease: ...

Source : http://www.med.unc.edu/medicine/web/8.1.07%20TTP%20HUS%20Parikh.ppt

Cervical/Vulvar Cancer - UNMC PPT

Presentation Summary : External beam pelvic radiation (4,000 to 6,000 cGy) Brachytherapy (8,000 to 8,500 cGy to Point A) I.V. Cisplatin chemotherapy Cisplatin 40mg/m2 (Max dose 70mg) ...

Source : http://www.unmc.edu/obgyn/docs/Cervicalvulvarcancer.ppt

Primary Chemoradiation Therapy with Cisplatin/5-FU for ... PPT

Presentation Summary : Title: Primary Chemoradiation Therapy with Cisplatin/5-FU for Locally Advanced HNSCC Author: dzaboli1 Last modified by: BMESSING Created Date: 9/2/2010 8:36:57 PM

Source : http://www.gbmc.org/workfiles/HeadNeck/GBMC_Primary%20CRT%20HNSCC_Brizel%20Cohort_Grand%20Rounds_12_4_2010.ppt

Clinical Trials in Ovarian Cancer PPT

Presentation Summary : Cisplatin (75 mg/m2 q21d x 6) PLUS. Cyclophosphamide (750 mg/m2) Cisplatin (75 mg/m2 q21d x 6) PLUS. Paclitaxel (135 mg/m2/24h) GOG 111: progression-free survival ...

Source : http://www.ovariancancer.org/wp-content/uploads/2010/11/Clinical-Trials-talk-for-Regional-Conf-FINAL-VERSION-copy.ppt

Preoperative Weekly Paclitaxel, Cisplatin and Radiation for ... PPT

Presentation Summary : Title: Preoperative Weekly Paclitaxel, Cisplatin and Radiation for Potentially Resectable Esophageal Carcinoma Author: NASHWA NAZMY Last modified by

Source : http://www.alawram.com/teaching/wilms.ppt

Chemotherapy and Renal Toxicity - UCLA Nephrology PPT

Presentation Summary : ... Cisplatin Clinical manifestations Acute kidney injury Hypomagnesemia from urinary magnesium wasting Fanconi-like syndrome Salt wasting Prevention of ...

Source : http://www.nephrology.med.ucla.edu/MiscFiles/diseasereview/Lau%20Chemotherapy%20Renal%20Toxicity.ppt

Chemotherapy and Head and Neck Cancer - Welcome to UTMB ... PPT

Presentation Summary : May replace cisplatin in future as most common agent Combination Chemotherapy Superior to single agents in almost all trials Ideal agents have synergistic ...

Source : http://www.utmb.edu/otoref/Grnds/Chemo-HN/Chemo-HN.pps

Chemotherapy of Head and Neck Cancer - Welcome to UTMB Health ... PPT

Presentation Summary : ... cisplatin Antimetabolites Cytotoxic effects via similarity in structure or function to naturally occurring metabolites involved in nucleic acid synthesis ...

Source : http://www.utmb.edu/otoref/Grnds/Chemo-030416/Chemo-slides-030416.ppt

Review of Conventional Chemotherapy Drugs PPT

Presentation Summary : ... docetaxel nab-paclitaxel Topoisomerase II inhibitors etoposide Platinum Complexes cisplatin, carboplatin oxaliplatin Anthracyclines doxorubicin, ...

Source : http://chicago.medicine.uic.edu/UserFiles/Servers/Server_442934/Image/Hematology/ppt/conv_chem.ppt

Slide 1 PPT

Presentation Summary : A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell ...

Source : http://l39gg632kcb0ewpfj-sites-default-files.s3.amazonaws.com/ASCO2011RTOG0522.ppt

TRACO: Cancer Treatment - NCI at Frederick: Staff Home Page PPT

Presentation Summary : Meta analysis SCLC LD Standard of treatment Approach to SCLC ED Standard of treatment for SCLC ED Cisplatin or Carboplatin plus Etoposide Median survival approx ...

Source : http://ncifrederick.cancer.gov/About/Section508/Examples/Giaccone08SCLC.ppt

Neo-adjuvant chemotherapy in Squamous cell carcinoma of head ... PPT

Presentation Summary : Dosage of Cisplatin in CRT 80% of pts tolerated > or = 6 doses of 30 mg/m2 weekly. Total: 180-210 mg 50% of pts tolerated 100 mg/m2 X 2.

Source : http://www.gbmc.org/workfiles/HeadNeck/ENT%20grandround%201-2011.ppt

Title of Module/Lecture - Gynecologic Cancer Intergroup Gcig PPT

Presentation Summary : AMENDMENT Regimen II: Concurrent Cisplatin and TPZ and Radiation Therapy (10/23/2007) Cisplatin 60mg/m2 (max = 105 mg) administered IV over 30-60 minutes days 1, ...

Source : http://gcig.igcs.org/files/Cervix%20Committee%20Trials.ppt

Bladder Cancer PPT

Presentation Summary : RR Cisplatin 30% Carboplatin 20% Gemcitabine 20-30% Ifosfamide 20% Chemotherapy for bladder cancer Combination chemotherapy. RR CR MVAC ...

Source : http://www.sasro.ch/SRO/Bladder.02.04.ppt

PowerPoint Presentation PPT

Presentation Summary : (mechlorethamine, cyclophosphamide, cisplatin) Induction of DNA repair enzymes (cisplatin, alkylators, bleomycin, any drug that damages DNA) ...

Source : https://courses.washington.edu/chat543/lectures/PowerPointSlides/CC_Resist%20Tox_07.ppt

PowerPoint Presentation PPT

Presentation Summary : ... Bleomycin contraindicated or dropped- EP X 4 5 day BEP less toxic and optimal regimen B 30 U d1,8,15 E 100mg/m2 1-5 Cisplatin 20mg/m21-5 Australian Germ ...

Source : http://www.igcs.org/files/Lectures/30/OvGermCellStromal_Friedlander_Leuven07.ppt

Chemotherapy of Medulloblastoma - University of Florida PPT

Presentation Summary : ... bifunctional alkylating agent related to nitrogen mustard Cisplatin – solution for injection; planar platinum bifunctional alkylating agent Carboplatin ...

Source : http://plaza.ufl.edu/m123/Chemotherapy%20of%20Medulloblastoma.ppt

Chemotherapy-Induced Peripheral Neuropathy: Why the complication? PPT

Presentation Summary : Cisplatin can unfortunately be long-lasting, and take even years to resolve. Click the arrow below to advance to the next slide. Rest and Review!

Source : http://faculty.alverno.edu/bowneps/MSN621/2008%20tutorials/Chemotherapy-Induced%20Peripheral%20Neuropathy%20tutorial.ppt


Presentation Summary : ... variation in sensitivity of various cancers to chemotherapy: Two Broad Classes of Chemotherapy Drugs: Cytotoxic agents Cisplatin – causes DNA damage 5 ...

Source : http://dental.case.edu/classnotes/year3/ocancer/10_chemotherapy.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com